Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Contract Win

20 Mar 2007 07:00

Embargoed Release: 07:00hrs Tuesday 20th March 2007

Sopheon plc (`Sopheon') Land O'Lakes to Deploy Sopheon's Product Life Cycle Management Solution

Leading Consumer Goods Company Adopts Accolade‚® to Automate Stage-Gate‚® Process

and Support Focus on High-Value Products

Sopheon, the international software and services company, announces today that Land O'Lakes, Inc., a leading dairy co-operative, is implementing Sopheon's Accolade product life cycle management (`PLM') system as the technology foundation for its product innovation processes. The solution will be used initially within the company's Dairy Foods business unit, where it will support cross-functional teams responsible for developing and commercializing new products. Plans include subsequent enterprise-wide deployment.

Headquartered in St. Paul, Minn., Land O'Lakes generates annual revenues of more than $7 billion and is one of the largest dairy co-ops in the U.S. It markets milk, spreads, cheeses and deli products to consumers, food services and food manufacturers throughout the world.

Land O'Lakes also offers an extensive line of agricultural supplies and state-of-the-art production, distribution and business services. During its 86-year history, the company has established a reputation for quality, strong brands and innovation.

Land O'Lakes has stated that one of its principal strategic goals is to incorporate best practices into all aspects of its operations. This focus is part of an overarching plan to drive additional revenues and profit growth from the company's core businesses. Actions include an initiative aimed at enhancing the process for product innovation.

Sopheon's system will be used to automate the Stage-Gate product development methodology being deployed by Land O'Lakes. Accolade will streamline the innovation process, making it easier to use and reducing the administrative burden otherwise associated with its implementation. Step-by-step task guidelines and Land O'Lakes' best-practice based report templates have been embedded in the software to support efficient process execution and successful completion of deliverables. The system will strengthen innovation process governance by providing decision support and controls that enable more informed prioritization of product development projects.

"Innovation is essential to our business success," said Tom Grueztmacher, vice-president of research and development at Land O'Lakes. "Accolade will automate our product development process and assist us in setting project priorities. Its capabilities will help to ensure that the right new products get to market, and get there on time. In designing our system we benefited from Sopheon's domain expertise in product-development best practices and the fact that they have installed and supported similar, successful systems for a substantial number of consumer packaged goods (CPG) companies. Their industry-specific know-how gave us an important leg up in developing a process in which we can have confidence."

"Business process improvement is a central strategic thrust for most companies today," said Andy Michuda, CEO of Sopheon. "And recent surveys consistently place product and service development processes among the top improvement priorities. The reasons are all about business. Improved innovation means substantial increases in portfolio net-present-value and, ultimately, higher profits, revenues and stakeholder returns. Land O'Lakes' aim is to compete not only with superior products, but also with superior product development processes. We are committed to helping them achieve that goal."

Land O'Lakes' deployment continues an extended pattern of Accolade adoption by major consumer goods manufacturers. Ten of the 100 companies comprising Consumer Goods Technology magazine's current registry of the world's largest consumer goods producers are using the Sopheon system. Examples include Cadbury Schweppes, Electrolux, Nestle, and Reckitt Benckiser.

-Ends-

Accolade‚® is a registered trademark of Sopheon plc.

Stage-Gate‚® is a registered trademark of the Product Development Institute.

All other trademarks and registered trademarks are the sole

property of their respective owners.

About Land O'Lakes

Land O'Lakes, Inc. is a farmer-owned food and agricultural cooperative with annual sales of more than $7 billion. Land O'Lakes does business in all 50 states and more than 50 countries. It is a leading marketer of a full line of dairy-based consumer, foodservice and food ingredient products across the United States; serves its international customers with a variety of food and animal feed ingredients; and provides farmers and ranchers with an extensive line of agricultural supplies (feed, seed, crop nutrients and crop protection products) and services. Land O'Lakes also provides agricultural assistance and technical training in more than 25 developing nations. For more information, please visit www.landolakesinc.com.

About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's Accolade system automates and governs the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Group Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010

SOPHEON PLC
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.